TGF beta Receptor II (17K1) Rabbit Monoclonal Antibody

TGF beta Receptor II (17K1) Rabbit Monoclonal Antibody

Cat: AMRe18849
Boyut:50μL Fiyat:$128_x000D_
Boyut:100μL Fiyat:$230_x000D_
Boyut:200μL Fiyat:$380_x000D_
Uygulama:ICC/IF,FC
Reaktivite:Human
Konjuge:Unconjugated
İsteğe bağlı konjugeler: Biotin, FITC (ücretsiz). Diğer 26 konjugatı görün.

Gen Adı:TGFBR2
Category: 組換えモノクローナル抗体 Tags: , , , , , ,
TGF beta Receptor II (17K1) Rabbit Monoclonal Antibody
Konjugasyon: Unconjugated
Recombinant rabbit monoclonal antibody
Uygulama
IHC  ICC/IF  ELISA ICC/IF,FC
Reaktivite
Human
Gen Adı
TGFBR2
Saklama
Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Özet
Ürün Adı TGF beta Receptor II (17K1) Rabbit Monoclonal Antibody
Açıklama Recombinant rabbit monoclonal antibody
Konak Rabbit
Reaktivite Human
Konjugasyon Unconjugated
Modifikasyon Unmodified
İzotip IgG
Klonalite Monoclonal
Form Liquid
Konsantrasyon Unconjugated
Saklama Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Nakliye Ice bags.
Tampon Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% New type preservative N and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
Saflaştırma Affinity purification
Antijen Bilgisi
Gen Adı TGFBR2
Alternatif İsimler TGF-beta receptor type-2; TGFR-2; TGFR2; TGF-beta type II receptor; TbetaR-II; TGFBR2;
Gen Kimliği 7048
SwissProt Kimliği P37173
İmmünojen Recombinant protein of human TGF beta Receptor II
Uygulama
Uygulama ICC/IF,FC
Seyreltme Oranı ICC/IF 1:500-1:1000,FC 1:20-1:50
Moleküler Ağırlık 65kDa
Araştırma Alanı
Signal Transduction
Arka Plan
TGFβs mediate their activity by high affinity binding to the type II receptor (TGFβ RII) transmembrane protein with a cytoplasmic serine-threonine kinase domain. For signaling growth inhibition and early gene responses the type II receptor requires both its kinase activity and association with a TGFβ-binding protein, designated the type I receptor. Two independent groups have recently described the cloning and sequence analysis of genes encoding TGFβ type I receptor proteins designated ALK-5 (TβR-1) and TSR-1, respectively. Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.
   💬 WhatsApp